Onto Innovation Completes Over $50 Million Series A Financing to Accelerate Deep Pipeline Expansion in Nucleic Acid Drugs
Focused on drug development based on antisense oligonucleotide technology.
高榕创投
@gaorong
创造美好生活
522 articles
Articles
Genmab Acquires ProfoundBio for $1.8 Billion | Gaorong Ventures News
Accelerate the development and unlock the full potential of ADC therapies.
Inside BYD: How "Yangwang" Is Redefining Disruptive Tech, and Decoding the "Xuanji" Intelligence System | Ronghui
Unwavering investment in disruptive new technologies.
High-end networking chip company **Zhuanxin** has completed its Series A2 funding round, targeting the AI computing network market.
Meeting the high-bandwidth networking demands of AI computing clusters.
Rongbao | Hydrogen energy and battery management tech firms secure new funding; innovative drug targets precise efficacy
Grow, toward the future.
ProfoundBio Closes $112 Million Series B to Advance ADC Drug Candidates Into Pivotal Clinical Development
Delivering breakthrough therapies for cancer patients.
Congratulations to Alto Neuroscience on its NYSE Listing, Advancing Precision Medicines in Mental Health | Gaorong Ventures News
Providing personalized and efficient treatment for patients with mental illness.
Chint Group's Taihydrogen Closes 150 Million Yuan Pre-A Round to Expand "Green Power + Green Hydrogen" Applications
Advance the development and application of hydrogen energy technology.
Huayi Quantum Secures Nearly 100 Million Yuan in Strategic Funding to Accelerate Commercialization of Ion-Trap Quantum Computing
Accelerate R&D and manufacturing of second- and third-generation trapped-ion quantum computers.
Xin'ai Technology Completes New Funding Round to Advance R&D and Mass Production of High-End Packaging Substrates
Accelerate the pace of scaled mass production and strengthen industrial layout in the automotive sector.